✨ Medicines Act Notices




710 NEW ZEALAND GAZETTE No. 27

Health

Medicines Act 1981

Corrigendum

Consent to the Distribution of a New Related Product

In the notice published in the New Zealand Gazette, 4 February 1999, No. 16, page 365, notice number 758, amend the first entry to show the Proprietary Name as Colgate Sensation Whitening Fluoride Toothpaste plus Tartar Control.

Dated this 28th day of February 1999.

G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.

go1722

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Gentamicin sulphate 2.9% w/w equivalent to 1.7% gentamicin Cement, bone DePuy CMW, Blackpool, United Kingdom CMW 1 Gentamicin Bone Cement
Gentamicin sulphate 2.9% w/w equivalent to 1.7% gentamicin Cement, bone DePuy CMW, Blackpool, United Kingdom CMW 3 Gentamicin Bone Cement
Raloxifene hydrochloride 60 mg equivalent to 56 mg raloxifene Tablet, film coated Eli Lilly & Company Limited, Basingstoke, Hampshire, England; and Lilly del Caribe Inc., Carolina, Puerto Rico Evista
Gentamicin sulphate 2.9% w/w equivalent to 1.7% gentamicin Cement, bone DePuy CMW, Blackpool, United Kingdom Vacu-Mix Plus (with CMW 1 Gentamicin Bone Cement)
Gentamicin sulphate 2.9% w/w equivalent to 1.7% gentamicin Cement, bone DePuy CMW, Blackpool, United Kingdom Vacu-Mix Plus (with CMW 3 Gentamicin Bone Cement)

Dated this 23rd day of February 1999.

G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.

go1560

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Somatropin 4IU: and benzyl alcohol 0.9% as diluent Injection, powder, with diluent Novo Nordisk A/S., Gentoft, Denmark Norditropin 4IU
Somatropin 12IU: and benzyl alcohol 0.9% as diluent Injection, powder, with diluent Novo Nordisk A/S., Gentoft, Denmark Norditropin 12IU
Somatropin 12IU: and benzyl alcohol 0.9% as diluent Injection, powder, with diluent Novo Nordisk A/S., Gentoft, Denmark Norditropin PenSet 12
Somatropin 24IU: and benzyl alcohol 0.9% as diluent Injection, powder, with diluent Novo Nordisk A/S., Gentoft, Denmark Norditropin PenSet 24


Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1999, No 27


NZLII PDF NZ Gazette 1999, No 27





✨ LLM interpretation of page content

πŸ₯ Corrigendum to Distribution Consent for Colgate Sensation Whitening Fluoride Toothpaste

πŸ₯ Health & Social Welfare
28 February 1999
Medicines Act 1981, Corrigendum, Distribution Consent, Toothpaste
  • G. R. Boyd, Chief Advisor, Regulation and Safety

πŸ₯ Consent to Distribution of New Medicines

πŸ₯ Health & Social Welfare
23 February 1999
Medicines Act 1981, Distribution Consent, New Medicines, Gentamicin, Raloxifene
  • G. R. Boyd, Chief Advisor, Regulation and Safety

πŸ₯ Consent to Distribution of Changed Medicines

πŸ₯ Health & Social Welfare
Medicines Act 1981, Distribution Consent, Changed Medicines, Somatropin